Active Ingredient(s): Icodextrin
FDA Approved: * December 20, 2002
Pharm Company: * BAXTER HLTHCARE
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Extraneal Overview

Icodextrin (INN, USAN) is a colloid osmotic agent, derived from maltodextrin,[1] used in form of an aqueous solution for peritoneal dialysis under the trade name Extraneal,[2] and after gynecological laparoscopic surgery for the reduction of post-surgical adhesions (fibrous bands that form between tissues and organs) under the trade name Adept.[3] Contents 1 Chemistry 2 Mechanism of action 3 Pharmacokinetics 4 Contraindications 5 Adverse effec...

Read more Extraneal Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Icodextrin

Recent Extraneal Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: 7.5gm/100ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Extraneal: (1 result)

Sorted by National Drug Code
  • 0941-0679 Extraneal Intraperitoneal Injection, Solution by Baxter Healthcare Corporation

Other drugs which contain Icodextrin or a similar ingredient: (1 result)